Mavorixafor
X4P-001-003
Phase 1 small_molecule active
Quick answer
Mavorixafor for Hepatic Insufficiency is a Phase 1 program (small_molecule) at X4 Pharmaceuticals, Inc with 1 ClinicalTrials.gov record(s).
Program details
- Company
- X4 Pharmaceuticals, Inc
- Indication
- Hepatic Insufficiency
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active